Lets not forget, when the deal was struck to re-issue the options there was minimal discussion regarding the variance between directors and shareholders issues but rather everyone seemed okay with what was proposed.
Unfortunately time has ticked away without sympathetic share price appreciation and the timeline for the options to be worth converting now looks highly unlikely to be met.
I think Management would be glad to see the options in the money as the inflow of cash from their conversion would sure the company up moving forward and would surely see the Artimist project concluded.
Kippax, I just can't see them around a table with a calculator and calendar doing back of envelope dilution calcs for their own benefit:)
DYOR.
- Forums
- ASX - By Stock
- oppies
Lets not forget, when the deal was struck to re-issue the...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMS (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online